Rx+ Business Accelerator

Pioneering solutions for patients with chronic disease

Digital Health Solutions
 astellas-com-en-rx-business-accelerator-mobile

The Rx+ Business Accelerator (Rx+BA) is dedicated to digital health, concentrating on the exploration and development of patient solutions that extend beyond traditional pharmaceuticals. We believe that by embracing advancements in digital technologies, we can unlock new opportunities for better health outcomes and a more proactive approach to patient care.

 

Powered by Astellas, the Rx+BA combines the experience, expertise, and resources of an established company with the agility and determination of a startup. Our mission is to deliver improved outcomes for individuals with chronic diseases through patient-facing, evidence-based digital health solutions.

 

Learn more about our leading digital health solutions below.

Leading programs

DIGITIVA™ – a non-invasive digital health solution for the management of heart failure, which was listed with the FDA in September 2024 and is the first digital health offering from Astellas in the United States.


BlueStar® Japan – a modified version of BlueStar adapted to Japanese diabetes care practices, currently under development in Japan by the Rx+BA for the management of diabetes.

  • BlueStar is a digital therapeutic designed to improve blood glucose levels in people living with diabetes. 
  • BlueStar empowers patients to take greater control of their health by offering a mobile application that provides real-time digital coaching on diet and exercise, as well as tracks blood glucose levels and medication.

Partner with Astellas

Are you interested to partner with Astellas and the Rx+ Business Accelerator? Click below to learn more.